COVAX Announces additional deals to access promising COVID-19 vaccine candidates; plans global rollout starting Q1 2021
COVAX now has agreements in place to access nearly two billion doses of several promising vaccine candidates, and laid the groundwork for further doses to be secured through contributions from donors These agreements mean that all COVAX’s 190 participating and eligible economies will be able to access doses to protect vulnerable groups in the first half of 2021. At least…
Read More
